Estimation of survival after AIDS diagnosis: CD4 T lymphocyte count versus clinical severity

Journal of Clinical Epidemiology

Volumn 49, Issue 1, 1996, Pages 59-65

  Turner, Barbara J ^a,c   Markson, Leona ^a   Taroni, Francesco ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c College Building ^*  (United States)

Author keywords

AIDS complications; AIDS epidemiology; AIDS mortality; CD4 positive T lymphocytes; Severity of illness index; Survival analysis

Indexed keywords

ALBUMIN; CD4 ANTIGEN; HEMOGLOBIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HELPER CELL; HUMAN; ITALY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0029970391     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00067-4     Document Type: Article

References (30)

1. Turner BJ, Hecht R, Ismail R. CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1. Arch Intern Med 1994; 154: 1561-1573.
2. Sande MA, Carpenter CCJ, Cobbs CG, Holmes KK, Sanford JP, et al. Antiretroviral therapy for adult HIV-infected patients. National Institute of Allergy and Infectious Diseases State-of-the Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. JAMA 1993; 270: 2583-2589.
3. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: 1-19.
4. Vella S, Chiesi A, Volpi A, et al. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions. JAMA 1994; 271: 1197-1199.
5. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 1388-1393.
6. Kaslow RA, Phair JP, Friedman HB, et al. Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency. A report of the Multicenter AIDS Cohort Study. Ann Intern Med 1987; 107:474-480.
7. Redfield RR, Wright DC, Tramont EC. The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med 1986; 314: 131-132.
8. Wenger JD, Whalen CC, Lederman MM, et al. Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 1988; 3: 464-470.
9. The WHO International Collaborating Group for the Study of the WHO Staging System. Proposed "World Health Organization staging system for HIV infection and disease": Preliminary testing by an international collaborative cross-sectional study. AIDS 1993; 7: 711-718.
10. Turner BJ, Markson LE, McKee L, Houchens R, Fanning T. The AIDS-defining diagnosis and subsequent complications: A survival-based severity index. J Acquir Immune Defic Syndr 1991; 4: 1059-1071.
11. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994; 271: 1083-1087.
12. Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW. Survival trends for patients with AIDS. JAMA 1990; 263: 402-406.
13. Markson LE, Turner BJ, McKee L, et al. Ambulatory Care for HIV/AIDS: Models and Outcomes. Year 1 Report, AHCPR Grant #HS 06465, February, 1994.
14. Blatt SP, Lucey CR, Butzin CA, Hendrix CW, Lucey DR. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA 1993; 269: 622-626.
15. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: 1s-15s.
16. Katz MH, Hauck WW. Proportional hazards (Cox) regression. J Gen Intern Med 1993; 8: 702-711.
17. Nightingale SD, Jockusch JD, Haslund I, Cal SX, Peterson DM, Loss SD. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection. Arch Intern Med 1993; 153: 1313-1318.
18. Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1412-1416.
19. Lundgren J, Phillips A, Pedersen C, et al. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994; 271: 1088-1092.
20. Turner BJ, Denison M, Eppes SC, Houchens R, Fanning T, Markson LE. Survival experience of 789 children with the acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993; 12: 310-320.
21. Yarchoan R, Venzon DJ, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 1991; 115: 184-189.
22. Stone VE, Seage GR, Hertz T, Epstein AM. The relationship between hospital experience and mortality for patients with AIDS. JAMA 1992; 268: 2655-2661.
23. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda. Ann Intern Med 1995; 122: 262-270.
24. Brettle RP, Gore SM, Bird AG, McNeil AJ. Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases. AIDS 1993; 7: 531-539.
25. Alcabes P, Schoenbaum EE, Klein RS. CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection. AIDS 1993; 7: 513-517.
26. Taylor J, Fahey J, Detels R, Giorgi J, CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acquir Immune Defic Syndr 1989; 2: 114-124.
27. Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med 1994; 154: 1497-1504.
28. Concorde Coordinating Committee. Concorde: MRC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343: 871-881.
29. Turner BJ, Markson LE, McKee LJ, Houchens R, Fanning T. Health care delivery, zidovudine use, and survival of women and men with AIDS. J Acquir Immune Defic Syndr 1994; 7: 1250-1262.
30. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994; 120:932-944.